丁兰芳, 王晓谦, 陆媛媛, 宋红林, 李 力, 张洁清. 雌二醇对子宫内膜癌细胞AKT通路中细胞因子的影响[J]. 中国肿瘤临床, 2011, 38(20): 1262-1266. DOI: 10.3969/j.issn.1000-8179.2011.20.007
引用本文: 丁兰芳, 王晓谦, 陆媛媛, 宋红林, 李 力, 张洁清. 雌二醇对子宫内膜癌细胞AKT通路中细胞因子的影响[J]. 中国肿瘤临床, 2011, 38(20): 1262-1266. DOI: 10.3969/j.issn.1000-8179.2011.20.007
Lanfang DING, Xiaoqian WANG, Yuanyuan LU, Honglin SONG, Li LI, Jieqing ZHANG. Effect of Estrogen on the Cytokines of AKT Signaling Pathway in Endometrial Cancer Cells[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 38(20): 1262-1266. DOI: 10.3969/j.issn.1000-8179.2011.20.007
Citation: Lanfang DING, Xiaoqian WANG, Yuanyuan LU, Honglin SONG, Li LI, Jieqing ZHANG. Effect of Estrogen on the Cytokines of AKT Signaling Pathway in Endometrial Cancer Cells[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 38(20): 1262-1266. DOI: 10.3969/j.issn.1000-8179.2011.20.007

雌二醇对子宫内膜癌细胞AKT通路中细胞因子的影响

Effect of Estrogen on the Cytokines of AKT Signaling Pathway in Endometrial Cancer Cells

  • 摘要: 通过17β雌二醇(E2)诱导人子宫内膜癌HEC-1A细胞产生不同细胞因子,探讨雌激素在子宫内膜癌发展中的作用。方法:以浓度为1×10-6 mol/L雌二醇(E2组)作用于HEC-1A细胞8h、12 h后,或1×10-6 mol/L雌激素受体抑制剂(ER组)、25×10-6 mol/L AKT抑制剂(AKT组)分别预处理HEC-1A细胞60min,各加入1×10-6 mol/L雌二醇作用8h和12h后;采用荧光定量PCR及ELISA技术,分别检测细胞内VEGF、bFGF、IL-8基因mRNA及细胞培养上清液中蛋白表达情况。Western Blot检测以1×10-6 mol/L雌二醇作用HEC-1A细胞15min后,细胞内AKT蛋白表达情况。结果:E2组的VEGF、bFGF、IL-8 mRNA及蛋白的表达均明显高于对照组(P<0.05);ER组VEGF、bFGF、IL-8 mRNA和蛋白的表达,与E2组相比较,除了8h的VEGF蛋白和12 h的IL-8 mRNA表达无显著性差异及12 h的VEGF mRNA表达稍增加外,均明显低于E2组(P<0.05);AKT组VEGF、bFGF、IL-8 mRNA和蛋白的表达,与E2组相比较,除了12 h的IL-8 mRNA表达无显著性差异外,均明显低于E2组(P<0.05)。雌二醇作用HEC-1A细胞15 min后,与对照组比较,细胞内p-AKT蛋白表达明显增强(P<0.05)。结论:雌二醇诱导子宫内膜癌产生细胞因子VEGF、bFGF、IL-8可能是通过激活AKT通路实现的。

     

    Abstract: To investigate the relationship between estrogen and the development of endometrial cancer. Methods: Real-time polymerase chain reaction ( PCR ) was used to detect VEGF, bFGF, and IL-8 mRNA expression in HEC-1A cells and an enzyme-linked immunosorbent assay ( ELISA ) was used to detect the VEGF, bFGF, and IL-8 proteins in the cell culture fluid after stimulation with 1 × 10-6 mol/L estradiol ( E2 group ) for 8 h or 12 h, and with 60 min pretreatment with 1 × 10-6 mol/L ER inhibitor ( ER group ) or 25 × 10-6 mol/L AKT inhibitor ( AKT group ) following stimulation with 1 × 10-6 mol/L estradiol for 8 h or 12 h. Western blot was used to detect AKT protein expression in the HEC-1A cells after stimulation with 1 × 10-6 mol/L estradiol for 15 min. Results: Real-time PCR and ELISA showed the mRNA and protein expression of VEGF, bFGF, and IL-8 in the E2 group was significantly higher than that in the control group ( P < 0.05 ). The mRNA and protein expression of VEGF, bFGF, and IL-8 in the ER group was significantly lower than that in the E2 group ( P < 0.05 ) except for the VEGF protein expression at 8 h and the IL-8 mRNA expression at 12 h. VEGF mRNA expression was slightly high in the E2 group at 12 h. The mRNA and protein expression of VEGF, bFGF, and IL-8 in the AKT group was significantly lower than that in the E2 group ( P < 0.05 ), except for IL-8 mRNA expression at 12 h. Western blot analysis showed that p-AKT protein expression in the HEC-1A cells after 15 min stimulation with 1 × 10-6 mol/L estradiol was markedly higher than that in the control group ( P < 0.05 ). Conclusion: Estrogen induced the production of VEGF, bFGF, and IL-8 through activating the AKT signal transmission pathway.

     

/

返回文章
返回